
Educational summary of peer-reviewed work on spinal disorders (not medical advice).
Article: Factors Associated With a Higher 30-Day Hospitalization Period for Pituitary Adenoma Patients: Introducing a Novel Outcome Metric.
Authors (excerpt): Anthony Tang, Hussein M Abdallah, Paul A Gardner, Georgios A Zenonos, Yue-Fang Chang
Overview: BACKGROUND AND OBJECTIVES: A novel metric that incorporates both length of stay (LOS) and readmission in 1 metric, the 30-day hospitalization ratio (HR) (total number of days of hospitalization/30 days) was applied to patients undergoing endonasal surgery for pituitary adenoma. The objectives of this study were to determine predictive factors associated with prolonged hospitalization and economic burden and to demonstrate the utility of 30-day HR as a novel outcome metric compared with LOS and readmission. METHODS: A retrospective chart review of 492 patients who underwent an endoscopic endonasal approach for pituitary adenoma at a Pituitary Tumor Center of Excellence between January 2015 and September 2022. The main outcome measures analyzed were LOS, readmission, and HR. RESULTS: Patients had an average age of 55.4 ± 16.5 years; there were slightly more male patients (53.8%), and patients were predominantly White (82.5%). 49.2%…
Full citation: Factors Associated With a Higher 30-Day Hospitalization Period for Pituitary Adenoma Patients: Introducing a Novel Outcome Metric.. Neurosurgery. PubMed: PMID 40304493; DOI: 10.1227/neu.0000000000003471.
Consult the original paper for methods, statistics, and clinical applicability.
Това е обобщение за пациенти и специалисти, базирано на официалното резюме в PubMed. Публикацията е в списание Neurosurgery и засяга теми, свързани с гръбначния стълб (диагностика, лечение или епидемиология — според съдържанието на оригиналната статия). Не замества очен преглед при лекар и не представлява персонализиран медицински съвет.
Заглавие: Spine literature: Factors Associated With a Higher 30-Day Hospitalization Period for Pituitary Adenoma Patients: Introducing a Novel Outcome Metric.
Оригинално резюме (английски, съкратено): BACKGROUND AND OBJECTIVES: A novel metric that incorporates both length of stay (LOS) and readmission in 1 metric, the 30-day hospitalization ratio (HR) (total number of days of hospitalization/30 days) was applied to patients undergoing endonasal surgery for pituitary adenoma. The objectives of this study were to determine predictive factors associated with prolonged hospitalization and economic burden and to demonstrate the utility of 30-day HR as a novel outcome metric compared with LOS and readmission. METHODS: A retrospective chart review of 492 patients who underwent an endoscopic endonasal approach for pituitary adenoma at a Pituitary Tumor Center of Excellence between January 2015 and September 2022. The main outcome measures analyzed were LOS, readmission,…
Source: Factors Associated With a Higher 30-Day Hospitalization Period for Pituitary Adenoma Patients: Introducing a Novel Outcome Metric.. Neurosurgery. PubMed: PMID 40304493; DOI: 10.1227/neu.0000000000003471.